KPV

KPV (Lys-Pro-Val)

What is it? KPV is a short peptide consisting of three amino acids and is derived from α-melanocyte-stimulating hormone (α-MSH). It is being researched primarily for its potential anti-inflammatory and immune-modulating properties. KPV is not approved by Health Canada or the FDA as a therapeutic drug.

Potential Research Benefits

May have anti-inflammatory properties

May support gastrointestinal and intestinal-barrier health

May help regulate inflammatory immune responses

May support skin health and recovery

Has been investigated in models of inflammatory bowel conditions

May have antimicrobial activity against certain microorganisms

May support tissue healing in preclinical research